Global University Venturing

UC Berkeley has chosen professor of finance Richard Lyons for the newly-created position of chief innovation and entrepreneurship officer.

Fidelity Management & Research has led a $325m series B round for Biontech, a spinout of Johannes Gutenberg University Mainz whose backers also include Sanofi and Pfizer.

Third Rock contributed to a $100m series C round for UIC's cancer drug developer Revolution that brought its total to $226m.

Building on UC Berkeley research, cybersecurity software company Menlo Security has now raised approximately $150m altogether.

University of Oxford's fifth innovation fund is seeking investors to help propel more promising spinouts and startups from the Oxford innovation ecosystem.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

MedaRed is targeting a blood-clotting factor called fibrin linked to neuron-toxic inflammation in diseases including Alzheimer’s, based on the work of Katerina Akassoglou at UCSF’s School of Medicine.

Two state-run initiatives targeting publicly-funded research have awarded $17.5m to programs including University of Auckland’s commercialisation arm, as New Zealand continues its bid to bring national R&D spend to 2% of GDP over the next decade.

Armed with findings from University of Oxford's Department of Zoology, Blue Water Vaccines believes it has the blueprint for a universal influenza vaccine.

The deadline for Roche’s $4.3bn purchase of CHOP's gene therapy developer Spark has been postponed until April 2020 amid regulatory scrutiny and pending lawsuits.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.